Articles with public access mandates - Björn Schumacher - British Heart FoundationLearn more
NoteFor this mandate, articles should be available from specific locations.
Not available based on mandate: 1
Review
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge, N Staplin, KJ Mayne, C Wanner, JB Green, SJ Hauske, ...
The Lancet Diabetes & Endocrinology 12 (1), 51-60, 2024
Available based on mandate: 1
Review
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
N Staplin, R Haynes, PK Judge, C Wanner, JB Green, J Emberson, ...
The Lancet Diabetes & Endocrinology 12 (1), 39-50, 2024
Publication and funding information is determined automatically by a computer program